• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药剂师主导的初级保健药物减量计划。

Pharmacist-driven deprescribing initiative in primary care.

出版信息

J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):139-145. doi: 10.1016/j.japh.2023.09.003. Epub 2023 Sep 16.

DOI:10.1016/j.japh.2023.09.003
PMID:37722503
Abstract

BACKGROUND

Polypharmacy, a broad term to describe the use of numerous and often unnecessary medications, has been connected to frailty, hospital admissions, falls, and even mortality. The Veterans Health Administration (VHA) developed the VIONE (vital, important, optional, not indicated, and every medication has an indication) dashboard to identify patients with polypharmacy and serve as a framework for deprescribing of medications across VHA facilities where it is used in a variety of practice settings by different disciplines.

OBJECTIVE

This study aimed to describe the implementation of a pharmacist-led, system-wide, deprescribing initiative in the primary care setting.

PRACTICE DESCRIPTION

Interdisciplinary education was provided through academic detailing. Subsequently, patients were identified for inclusion in the project using the VIONE dashboard focusing on those at highest risk of polypharmacy and moving down to the lowest risk. Interested patients underwent a medication reconciliation. A clinical pharmacist practitioner (CPP) then contacted the patient to discuss potential deprescribing options. Recommendations were relayed to the primary care provider (PCP) for final approval and communicated to the patient by the pharmacy team.

PRACTICE INNOVATION

Primary care CPPs (n = 3) integrated deprescribing into their standard workload. This service was implemented in the primary care setting across an entire health care system consisting of 16 different primary care teams.

EVALUATION METHODS

The initiative's impact was measured by the number of discontinued medications, the acceptance rate of recommendations by the PCP, the potential annualized cost avoidance, and the number of patients referred to CPP medication management clinics.

RESULTS

Among 63 patients, a total of 352 medications were deprescribed resulting in a potential annualized cost avoidance of $184,221. The acceptance rate of discontinuation recommendations was 96.7%. Subsequently, 25.4% of patients were referred to pharmacist-led clinics for disease state management.

CONCLUSION

Embedding deprescribing into standard CPP workflow within the primary care setting facilitated a way for polypharmacy reduction and allowed the expansion of pharmacy-led services at VA Butler Healthcare System.

摘要

背景

多种药物治疗,一个广义的术语,描述了使用大量且往往不必要的药物,与虚弱、住院、跌倒甚至死亡有关。退伍军人健康管理局(VHA)开发了 VIONE(重要、必要、可选、不推荐和每种药物都有适应证)仪表板,以确定患有多种药物治疗的患者,并作为在 VHA 设施中减少药物治疗的框架,在各种实践环境中,不同学科都在使用。

目的

本研究旨在描述在初级保健环境中实施的药剂师主导的、全系统的减药计划。

实践描述

通过学术详细说明提供跨学科教育。随后,使用 VIONE 仪表板确定符合项目条件的患者,重点关注高风险的多种药物治疗患者,然后逐步降低风险。有兴趣的患者进行药物重新调整。然后,临床药剂师从业者(CPP)联系患者讨论潜在的减药选择。建议转达给初级保健提供者(PCP)进行最终批准,并由药剂团队告知患者。

实践创新

初级保健 CPP(n=3)将减药纳入其标准工作量。该服务在整个医疗保健系统的 16 个不同的初级保健团队中实施。

评估方法

通过停止使用的药物数量、PCP 对建议的接受率、潜在的年化成本避免以及转介给 CPP 药物管理诊所的患者数量来衡量该计划的影响。

结果

在 63 名患者中,共停用了 352 种药物,潜在的年化成本避免了 184,221 美元。停止使用建议的接受率为 96.7%。随后,25.4%的患者被转介到药剂师主导的诊所进行疾病管理。

结论

在初级保健环境中,将减药纳入标准 CPP 工作流程为减少多种药物治疗提供了一种方法,并允许在 VA Butler 医疗保健系统中扩展药剂师主导的服务。

相似文献

1
Pharmacist-driven deprescribing initiative in primary care.药剂师主导的初级保健药物减量计划。
J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):139-145. doi: 10.1016/j.japh.2023.09.003. Epub 2023 Sep 16.
2
Reprint of: Pharmacist-driven deprescribing initiative in primary care.转载自:初级保健中药师主导的药物减量计划。
J Am Pharm Assoc (2003). 2024 Jul-Aug;64(4S):102162. doi: 10.1016/j.japh.2024.102162. Epub 2024 Aug 10.
3
Use of a Deprescribing Tool in an Interdisciplinary Primary-Care Patient-Aligned Care Team.在跨学科基层医疗患者导向型护理团队中使用减药工具。
Sr Care Pharm. 2022 Jan 1;37(1):34-43. doi: 10.4140/TCP.n.2022.34.
4
Informatics Tools in Deprescribing and Medication Optimization in Older Adults: Development and Dissemination of VIONE Methodology in a High Reliability Organization.老年人药物停用和优化中的信息学工具:在高可靠性组织中 VIONE 方法的开发和传播。
Clin Ther. 2023 Oct;45(10):928-934. doi: 10.1016/j.clinthera.2023.07.021. Epub 2023 Sep 9.
5
A virtual breakthrough series collaborative to support deprescribing interventions across Veterans Affairs healthcare settings.一个虚拟突破系列合作,以支持退伍军人事务医疗保健环境中的减药干预措施。
J Am Geriatr Soc. 2023 Sep;71(9):2935-2945. doi: 10.1111/jgs.18474. Epub 2023 Jun 19.
6
Implementation of a Pharmacist-Driven Aspirin Deprescribing Protocol Among Older Veterans in a Primary Care Setting.在初级保健环境中实施药师主导的老年退伍军人阿司匹林减量方案。
Sr Care Pharm. 2024 Jun 1;39(6):228-234. doi: 10.4140/TCP.n.2024.228.
7
Implementation of a compulsory clinical pharmacist-led medication deprescribing intervention in high-risk seniors in the emergency department.在急诊科对高危老年人实施由临床药师主导的强制性减药干预措施。
Acad Emerg Med. 2023 Apr;30(4):410-419. doi: 10.1111/acem.14699. Epub 2023 Mar 22.
8
Impact of deprescribing rounds on discharge prescriptions: an interventional trial.减药查房对出院处方的影响:一项干预性试验。
Int J Clin Pharm. 2019 Feb;41(1):159-166. doi: 10.1007/s11096-018-0753-2. Epub 2018 Nov 27.
9
Pharmacist-led telehealth deprescribing for people living with dementia and polypharmacy in primary care: A pilot study.药剂师主导的远程医疗减药用于初级保健中患有痴呆症和多种药物治疗的人群:一项试点研究。
J Am Geriatr Soc. 2024 Jul;72(7):1973-1984. doi: 10.1111/jgs.18867. Epub 2024 Mar 15.
10
A pharmacist-led pilot program to facilitate deprescribing in a primary care clinic.药剂师主导的试点计划,以促进在初级保健诊所中进行减药。
J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):105-111. doi: 10.1016/j.japh.2019.09.011. Epub 2019 Nov 2.

引用本文的文献

1
Barriers to and Enablers of Supporting Deprescribing Benzodiazepines in Older Adults: A Survey of European Nonphysician Healthcare Professionals.老年人停用苯二氮䓬类药物的支持障碍与促进因素:一项针对欧洲非医师医疗保健专业人员的调查
Basic Clin Pharmacol Toxicol. 2025 Oct;137(4):e70100. doi: 10.1111/bcpt.70100.
2
The role of U.S. pharmacists in deprescribing: Recommendations based on a systematic literature review of qualitative studies.美国药剂师在减药方面的作用:基于对定性研究的系统文献综述所提出的建议
Explor Res Clin Soc Pharm. 2025 Jun 24;19:100625. doi: 10.1016/j.rcsop.2025.100625. eCollection 2025 Sep.
3
Current Landscape and Future Directions of Deprescribing and Polypharmacy Practices in Jordan.
约旦撤药和多重用药实践的现状与未来方向
Med Princ Pract. 2024;33(6):505-518. doi: 10.1159/000541009. Epub 2024 Aug 19.